Article
Adenoviral expression of vascular endothelial growth factor splice variants differentially regulate bone marrow‐derived mesenchymal stem cells
20 Feb 2008
Abstract excerpt
Bone marrow-derived mesenchymal stem cells (MSCs) are being explored for clinical applications, and genetic engineering represents a useful strategy for boosting the therapeutic potency of MSCs. Vascular endothelial growth factor (VEGF)-based gene therapy protocols have been used to treat tissue ischemia, and a combined VEGF/MSC therapeutics is appealing due to their synergistic paracrine actions. However,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
